Outlook Therapeutics (NASDAQ:OTLK – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report ...

HC Wainwright restated their buy rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a research report report published on Wednesday morning,Benzinga reports. The firm currently ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Fintel reports that on November 26, 2024, HC Wainwright & Co. downgraded their outlook for Cassava Sciences (NasdaqCM:SAVA) ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

We recently published a list of 10 Best Silver Mining Stocks to Buy Right Now. In this article, we are going to take a look at where MAG Silver Corp.

Analysts at HC Wainwright upped their price target on the shares of MAG Silver Corp. (NYSE:MAG) from $17.00 to $18.00, giving ...

H.C. Wainwright raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $73 from $61 and keeps a Buy rating on the shares. The firm says Tarsus continues to beat estimates and that it ...

HC, which downgraded Ardelyx to Neutral from ... uncertainty around Medicare patient access for XPHOZAH,” noted H.C. Wainwright analyst Ed Arce. Citi also reduced its price target for the ...